Discover the Latest BUSINESS Insights and Trends
Stay informed on Odense´s dynamic ecosystemOdense Robotics Insight Report 2026
Download
State of the Danish Robotics Investment Landscape 2024
Download
5 TIPS FOR RAISING STARTUP CAPITAL AND NAVIGATING THE INVESTOR LANDSCAPE
Download
Fact sheet biotech and life science in odense 2023
Download
State of the Danish Robotics Investment Landscape 2022
Download
Female entrepreneurs in Odense Municipality 2022
Download
Let’s get in contact
Mette Falk
Marketing Manager - Invest in Odense
As the Marketing Manager for Invest in Odense, I am passionate about showcasing the strengths and potential our city holds. With a background steeped in marketing and a deep affection for the city of Odense, I am excited to lead initiatives that position Odense as a global hub within our specific strongholds.
+45 2368 8982
mefal@odense.dk
Connect
OUR Latest press releases
Odense takes the lead: 14 Million DKK to Boost Competencies in the Life Science Sector
With a fresh injection of 14 million DKK UCL University College is set to transform Denmark’s life science sector by placing Odense firmly on the map as the nation’s innovation powerhouse. As the coordinating hub for a nationwide upskilling initiative, Odense is sending a clear signal to international investors: this is where the future of life science is being shaped.
Global investment meets Odense innovation – Evosep enters a new era in clinical proteomics
With Nordic Capital as majority shareholder, Evosep strengthens its global position – and Odense’s role as a rising life science city. The recent acquisition of Evosep by Nordic Capital marks the biggest direct life science exit in EIFO history. It’s a clear signal that Denmark is not just participating in the global health innovation race – we’re building companies that can lead it.
Inverna Therapeutics Receives Major Grant from the Michael J. Fox Foundation to Boost Parkinson’s Research
Inverna Therapeutics has been awarded a USD 700,000 research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), one of the world’s leading supporters of Parkinson’s innovation. The funding will help advance Inverna’s next-generation RNA therapy, a new approach aimed at slowing or stopping the progression of Parkinson.